INS and type 2 diabetes mellitus: On the other hand, another study showed that insulin treatment was a significant (HR 2.10 [1.42-3.10]; 95% CI; p= 0.0002) risk factor for MACEs, conveying the complexity in managing T2DM and highlighting the need for alternative therapeutic approaches [7].